To investigate if MYC overexpression is sufficient to induce HCC in our model system, we removed doxycycline treatment in adult mice (6–12 weeks of age) transgenic for both TRE-MYC and LAP-tTA. This evidence concerns the gene MYC and hepatocellular carcinoma.